HAMAD MEDICAL CORPORATION

🇶🇦Qatar

Country: 🇶🇦Qatar

Ownership: -

Established: 1979-01-01

Employees: -

Market Cap: -

Website: https://www.hamad.qa

Clinical Trials

Nebulized 5% Hypertonic Saline for the Treatment of Bronchiolitis

Phase 4

Completed

Conditions: Bronchiolitis

Interventions: Drug: Treatment 1. (5% Hypertonic saline + Epinephrine)
Drug: Treatment 3. (3% Hypertonic saline + Epinephrine)
Drug: Treatment 2. (Normal saline + Epinephrine)

First Posted Date: 2009-11-19

Last Posted Date: 2009-11-19

Lead Sponsor: Hamad Medical Corporation

Target Recruit Count: 187

Registration Number: NCT01016249

Locations: 🇶🇦
Pediatric Emergency Center, Al-Saad, Doha, Qatar

© Copyright 2024. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy